Skip to main content
    T

    Tectonic Therapeutic, Inc. (TECX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $21.30
    +0.34 (+1.62%)

    Market Cap: $409.75M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    45%(13/29)
    Avg Surprise
    -12.29%
    Streak
    1 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-1.33
    Range$-1.54 - $-1.09
    8 analysts
    EPS RevisionsNo revisions (7d)
    0
    1
    30d
    EPS Estimate DriftChange to current
    90d ago$-1.37+2.8%
    60d ago$-1.37+2.8%
    30d ago$-1.330.0%
    7d ago$-1.330.0%
    Current$-1.33
    Revenue Consensus
    $0
    Range$0 - $0
    8 analysts
    Period ending Dec 31, 2026
    EPS Consensus$-1.23
    Range$-1.58 - $-0.53
    8 analysts
    Revenue Consensus
    $0
    Range$0 - $0
    8 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-1.23---
    Sep 26EST
    		-$-1.33---
    Jun 26
    Reported Aug 6
    		$-1.18$-1.41+16.31%Beat-10.3%
    Mar 26
    Reported May 7
    		$-1.34$-1.17-14.53%Miss-44.1%
    Dec 25
    Reported Feb 26
    		$-1.03$-1.11+7.21%Beat-23.1%
    Sep 25
    Reported Nov 6
    		$-1.02$-1.05+2.86%Beat+15.0%
    Jun 25
    Reported Aug 7
    		$-1.07$-0.98-9.18%Miss+75.3%
    Mar 25
    Reported May 8
    		$-0.93$-1.09+14.68%Beat+48.3%
    Dec 24
    Reported Mar 20
    		$-0.84$-1.39+39.68%Beat-67.3%
    Sep 24
    Reported Nov 7
    		$-1.20$-0.84-42.86%Miss-150.0%
    Jun 24
    Reported Aug 14
    		$-4.34$-1.30-233.85%Miss-385.5%
    Mar 24
    Reported May 9
    		$-1.80$-0.36-400.00%Miss-215.8%
    Dec 23
    Reported Mar 14
    		$-0.50$-0.43-16.28%Miss+12.3%
    Sep 23
    Reported Nov 9
    		$-0.48$-0.35-35.21%Miss+7.7%
    Jun 23
    Reported Sep 28
    		$1.52$-0.54+381.01%Beat+337.5%
    Mar 23
    Reported Jun 28
    		$-0.57$-0.55-3.64%Miss+16.2%
    Dec 22
    Reported Mar 29
    		$-0.57$-0.49-15.64%Miss+12.3%
    Sep 22
    Reported Nov 8
    		$-0.52$-0.55+5.45%Beat+30.7%
    Jun 22
    Reported Sep 28
    		$-0.64$-0.57-11.85%Miss+13.5%
    Mar 22
    Reported Jun 28
    		$-0.68$-0.58-16.88%Miss-4.6%
    Dec 21
    Reported Mar 29
    		$-0.65$-0.74+12.10%Beat+11.0%
    Sep 21
    Reported Dec 29
    		$-0.75$-0.76+1.04%Beat+25.7%
    Jun 21
    Reported Sep 28
    		$-0.74$-0.66-11.78%Miss+7.5%
    Mar 21
    Reported Jun 29
    		$-0.65$-0.75+13.77%Beat+15.6%
    Dec 20
    Reported Mar 30
    		$-0.73$-0.89+17.75%Beat-1.4%
    Sep 20
    Reported Nov 5
    		$-1.01$-0.80-26.71%Miss-77.2%
    Jun 20
    Reported Aug 6
    		$-0.80$-0.76-5.26%Miss-19.4%
    Mar 20
    Reported Jun 29
    		$-0.77$-0.66-16.67%Miss+91.0%
    Dec 19
    Reported Mar 30
    		$-0.72$-0.59-22.03%Miss+91.1%
    Sep 19
    Reported Nov 7
    		$-0.57$-0.59+3.39%Beat+90.3%
    Jun 19
    Reported Aug 8
    		$-0.67$-0.75+10.67%Beat+87.4%
    Mar 19
    Reported Jun 29
    		$-8.59N/AN/ABeat-
    Dec 18
    Reported Mar 30
    		$-8.08N/AN/ABeat-
    Sep 18
    Reported Nov 13
    		$-5.86N/AN/ABeat-
    Jun 18
    Reported Aug 9
    		$-5.32N/AN/ABeat-

    Key Metrics

    Valuation
    P/E Ratio-4.66EV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-33.80%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest Coverage-2377.05x
    Current Ratio22.29xQuick Ratio22.29x
    Trading Statistics
    Beta0.38Avg Volume246.25K
    52-Week High$39.5352-Week Low$15.52

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$22.28
    SMA 20$23.42
    SMA 50$28.95
    SMA 200$28.08
    EMA 10$22.29
    EMA 20$23.75
    EMA 50$26.89
    EMA 200$27.44

    MACD

    Line: -2.04Signal: -2.11Hist: 0.07

    ADX

    ADX: 46.8+DI: 7.8-DI: 29.4

    Aroon & PSAR

    Aroon Up8.0
    Aroon Down96.0
    PSAR$23.44

    Bollinger Bands

    Upper Band$26.83
    Lower Band$20.02
    %B Position2910%(Upper)
    Band Width0.19

    RSI (14-Day)

    Oversold
    29.1

    Momentum Oscillators

    Stoch %K11.4
    Stoch %D13.1
    Williams %R-82.3
    ROC (10d)-6.0%
    Momentum-1.37
    CCI (20d)-112.8
    MFI (14d)23.2

    Volatility Measures

    ATR (14d)$1.42(6.6%)
    StdDev (20d)1.70
    Hist Vol36.3%(Moderate)

    Volume Flow

    VWAP$21.29
    OBV-6.3M
    AD Line-6.9M
    CMF (20d)-0.107

    Volume Metrics

    Avg Vol (20d)252.1K
    Vol Ratio0.7x
    VWMA (20d)$23.45

    Pivot Points

    R3$22.75
    R2$22.25
    R1$21.60
    Pivot Point$21.10
    S1$20.46
    S2$19.96
    S3$19.32

    Advanced Oscillators

    TSI-41.88
    Ultimate Osc45.0
    KST-256.32

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$0$0$0$0$0$0$0$0$0$0$0$0
    Cost of Revenue$0$0N/A$0$0$0$508,000$0$0$0$373,000$0
    Gross Profit$0$0N/A$0$0$0$-508,000$0$0$0$-373,000$0
    Operating Expenses$24.22M$27.30M$21.52M$21.89M$22.33M$18.30M$13.99M$19.64M$11.42M$12.97M$-1,317,000$10.11M
    R&D$18.05M$20.87M$16.34M$16.93M$17.18M$13.04M$9.15M$14.32M$7.07M$10.82M$2.73M$8.13M
    SG&A$6.17M$6.43M$5.17M$4.96M$5.15M$5.26M$4.83M$5.32M$4.35M$2.15M$-4,050,000$1.98M
    Operating Income$-24,218,000$-27,301,000$-21,516,000$-21,890,000$-22,332,000$-18,298,000$-13,989,000$-19,637,000$-11,421,000$-12,968,000$1.32M$-10,114,000
    Interest Income$2.02M$2.18M$2.56M$2.90M$3.39M$2.44M$1.74M$1.95M$318,000$256,000$12,000$97,000
    Interest Expense$6,000$8,000$12,000$14,000$17,000$20,000$23,000$25,000$28,000$31,000$0$36,000
    Income Before Tax$-22,208,000$0$-18,972,000$-19,035,000$-19,008,000$0$-12,373,000$-17,717,000$-12,671,000$-15,221,000$2.90M$-10,054,000
    Income Tax Expense$77,000$0$0$0$976,000$0$0$0$0$0$0$0
    Net Income$-22,285,000$-25,241,000$-19,226,000$-19,035,000$-19,984,000$-15,906,000$-12,373,000$-17,717,000$-12,671,000$-15,221,000$2.64M$-10,054,000
    EBITDA$-23,509,000$-26,614,000$-21,191,000$-21,579,000$-22,040,000$-17,970,000$-13,577,000$-19,220,000$-12,625,000$-15,069,000$3.33M$-9,744,000
    EBIT$-24,223,000$-27,414,000$-21,524,000$-21,921,000$-22,380,000$-18,330,000$-14,085,000$-19,644,000$-12,961,000$-15,446,000$2.96M$-10,115,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about TECX

    News

    Price-Driven Insight from (TECX) for Rule-Based Strategy

    This article provides a price-driven insight for Avrobio Inc. (NASDAQ: TECX), noting weak near and mid-term sentiment but a strong long-term positive outlook. It presents AI-generated trading strategies including...

    Stock Traders Daily•9/25/26•Somewhat-Bearish

    Behavioral Patterns of TECX and Institutional Flows

    This article analyzes Avrobio Inc. (NASDAQ: TECX), indicating strong sentiment across all horizons and an exceptional 58.8:1 risk-reward setup targeting a 17.8% gain. It details three AI-generated institutional trading...

    Stock Traders Daily•8/15/26•Bullish

    Behavioral Patterns of TECX and Institutional Flows

    This article analyzes Avrobio Inc. (NASDAQ: TECX) using AI models to identify behavioral patterns and institutional flows. Key findings include strong sentiment across all time horizons, supporting an overweight bias...

    Stock Traders Daily•8/15/26•Bullish

    (TECX) Movement Within Algorithmic Entry Frameworks

    This article analyzes Avrobio Inc. (NASDAQ: TECX) using algorithmic entry frameworks. It highlights a weak near and mid-term sentiment but a strong long-term outlook...

    Stock Traders Daily•8/4/26•Somewhat-Bullish

    How (TECX) Movements Inform Risk Allocation Models

    This article analyzes Avrobio Inc. (NASDAQ: TECX) using AI models to inform risk allocation. It highlights divergent sentiment, suggesting choppy conditions, and details three trading strategies: Position Trading...

    Stock Traders Daily•7/23/26•Somewhat-Bearish

    TECX Valuation and Fair Value

    P/E
    -4.7x
    P/B
    1.8x
    See GNG's fair value

    TECX Profitability: Margins, ROIC and FCF

    Operating margin
    0.0%
    Net margin
    0.0%
    ROE
    -33.8%

    TECX Competitors

    CompanyTicker
    DiaMedica Therapeutics IncDMAC
    Rezolute IncRZLT
    Prenetics Global LtdPRE
    Avita Medical LtdRCEL
    Community Health Systems IncCYH
    Myriad Genetics IncMYGN
    Zura Bio Limited Class A Ordinary SharesZURA
    ARS Pharmaceuticals, IncSPRY

    Sector: Healthcare

    TECX Analyst Ratings

    Consensus
    Buy
    Analysts
    9
    Strong Buy
    1
    Buy
    8
    Hold
    0
    Sell
    0
    Strong Sell
    0

    TECX Bull Case vs Bear Case

    Bull case

    • 100.0% of TECX's analyst ratings are Buy or Strong Buy.

    TECX Earnings: Beat Rate and Next Report

    Beat rate
    5 of 8 quarters (62.5%)
    Average surprise
    1.8%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-1.33
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    0 up, 1 down

    Frequently Asked Questions About TECX

    Does TECX pay dividends?

    Tectonic Therapeutic, Inc. (TECX) does not currently pay a regular dividend.

    What is TECX's market cap?

    Tectonic Therapeutic, Inc. (TECX) has a market capitalization of $409.75M with a current stock price of $21.30.

    Related stocks

    Sector: Healthcare

    All stocks starting with T

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In